✦ LIBER ✦

Phase III trial comparing epirubicin/paclitaxel vs epirubicin/cyclophosphamid as first line treatment in metastatic breast cancer: Preliminary results of a German AGO trial

✍ Scribed by G. von Minckwitz; W. Kuhn; C. Thomssen; M. Untch; Th. Bauknecht; D. Eidtmann; V. Möbus; A. du Bois; H.-J. Lück

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase III trial of liposomal doxorubicin

✍ Chan, S. 📂 Article 📅 2004 🏛 Oxford University Press 🌐 English ⚖ 91 KB

Capecitabine plus paclitaxel versus epir

✍ Hans-Joachim Lück, Andreas Du Bois, Sibylle Loibl, Iris Schrader, Jens Huober, V 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 279 KB

Multicentric phase II trial of gemcitabi

✍ Cappuzzo, F; Mazzoni, F; Gennari, A; Donati, S; Salvadori, B; Orlandini, C; Cett 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 90 KB

Multicenter randomized phase III trial o

✍ Baldini, E; Prochilo, T; Salvadori, B; Bolognesi, A; Aldrighetti, D; Venturini, 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 101 KB

Gemcitabine, Epirubicin, and Paclitaxel

✍ Seidman, A.D. 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 53 KB

Gemcitabine, epirubicin and paclitaxel (

✍ T. Brodowicz; S. Beslija; J. Cervek; Z. Mrsic-Krmpotic; I. Tchernozemsky; C. Wil 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 166 KB